Medscape

Medscape InDiscussion: Myasthenia Gravis

Science EN ↓ 6 episodi

Listen to Medscape InDiscussion: Myasthenia Gravis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989800). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Visita il sito del podcast e sostieni chi lo crea: www.medscape.com

Autore

Medscape

Categoria

Science

Sito del podcast

www.medscape.com

Ultimo episodio

24 ott 2023

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

Managing Myasthenia Gravis in Primary Care: Best Practices 24.10.2023

Drs Nicholas Silvestri and Michael Hehir discuss best practices for primary care physicians who see patients with myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990463). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare profe...

Myasthenia Gravis: Exercise and Lifestyle Considerations 21.09.2023

Drs Nicholas Silvestri and Kelly Gwathmey discuss how exercise and other modifiable lifestyle factors can influence how patients experience the burden of myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990462). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast...

Myasthenia Gravis: Who Really Benefits From Thymectomy? 23.08.2023

Drs Nicholas Silvestri and Gil Wolfe get right to the point about when and why thymectomy may be considered as an evidence-based option for treatment of myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990461). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast i...

Tools for More Personalized Myasthenia Gravis Care 25.07.2023

Drs Nicholas Silvestri and James "Chip" Howard discuss newer and novel myasthenia gravis tools to personalize treatment, including complement inhibitors, FcRn antagonists, biomarkers, and more. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990460). The topics and discussions are planned, produced, and reviewed independently of adver...

Treating Myasthenia Gravis? Don't Stop at Pyridostigmine 22.06.2023

Drs Nicholas Silvestri and Neelam Goyal lay out pathways for successful routine treatment of myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990458). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources A...

Myasthenia Gravis: Which Test Is Best? When and Why? 22.06.2023

Drs Nicholas Silvestri and Carolina Barnett-Tapia discuss what you need to know about immunopathogenesis and diagnosis for this relatively rare condition. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989800). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only f...

Ascolta il podcast Medscape InDiscussion: Myasthenia Gravis su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici